Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SC BioSciences Corporation is a specialized Japanese company that provides advanced research tools and services to the life sciences, biotechnology, and pharmaceutical industries. As a wholly-owned subsidiary of Sumitomo Corporation, the company acts as a strategic bridge, importing and distributing innovative laboratory equipment, reagents, and diagnostic products from global manufacturers to the Japanese market. Their portfolio is particularly strong in the areas of cell culture, regenerative medicine, and drug discovery support. In addition to product distribution, SC BioSciences offers technical consulting and contract research services to assist researchers in optimizing their workflows. The company's mission is to accelerate scientific advancement by providing high-quality, cutting-edge technologies to academic and industrial laboratories across Japan. By leveraging the global network of its parent company, SC BioSciences remains at the forefront of introducing new methodologies to the Japanese scientific community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SC BioSciences.